<!DOCTYPE html>
<html><head><meta name="GCD" content="YTk3ODQ3ZWZhN2I4NzZmMzBkNTEwYjJl6916748ff9b346c0c92fb5bb35edbb51"/>
  <meta charset="utf-8">
  <meta name="generator" content="Google Web Designer 16.0.2.0124">
  <meta name="template" content="Banner 3.0.0">
  <meta name="environment" content="gwd-genericad">
  <meta name="ad.size" content="width=320,height=50">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link href="gwdpage_style.css" rel="stylesheet" data-version="13" data-exports-type="gwd-page">
  <link href="gwdpagedeck_style.css" rel="stylesheet" data-version="14" data-exports-type="gwd-pagedeck">
  <link href="gwdtaparea_style.css" rel="stylesheet" data-version="7" data-exports-type="gwd-taparea">
  <link href="gwdimage_style.css" rel="stylesheet" data-version="17" data-exports-type="gwd-image">
  <script type="text/javascript" src="autodivscroll.js"></script>
  <style type="text/css" id="gwd-lightbox-style">.gwd-lightbox{overflow:hidden}</style>
  <style type="text/css" id="gwd-text-style">::-webkit-scrollbar{width:10px}::-webkit-scrollbar-track{background:#f1f1f1}::-webkit-scrollbar-thumb{background:#888}::-webkit-scrollbar-thumb:hover{background:#555}p{margin:0px;padding-bottom:3px}sup{line-height:0;font-size:70%}ul{list-style-position:outside;padding-left:15px;padding-top:0px;margin-top:1px;margin-bottom:3px}ul li{margin-bottom:3px;margin-top:0px;padding-top:0px}li span{position:relative;left:-4px;font-weight:bold}h2{margin:0px}h3{margin:0px}</style>
  <script src="css_style.js"></script>
  <style data-gwd-secondary-animations="">#page1.gwd-play-animation .event-1-animation{animation:6s linear 0s 1 normal forwards gwd-empty-animation}@keyframes gwd-empty-animation{0%{opacity:0.001}100%{opacity:0}}</style>
  <script data-source="gwd_webcomponents_v1_min.js" data-version="2" data-exports-type="gwd_webcomponents_v1" src="gwd_webcomponents_v1_min.js"></script>
  <script data-source="gwdpage_min.js" data-version="13" data-exports-type="gwd-page" src="gwdpage_min.js"></script>
  <script data-source="gwdpagedeck_min.js" data-version="14" data-exports-type="gwd-pagedeck" src="gwdpagedeck_min.js"></script>
  <script type="text/javascript" gwd-events="support" src="gwd-events-support.1.0.js"></script>
  <script type="text/javascript" gwd-events="handlers">
  var clickTag = "https://www.odomzo.com/ODOMZO-(sonidegib)-Prescribing-Information-August-2023_96.pdf"
  window.gwd=window.gwd||{};gwd.startAutoScroll=function(event){new AutoDivScroll("scrollingISI",null,null,null,"endstop")};gwd.auto_Gwd_taparea_1Action=function(event){gwd.actions.gwdGenericad.exit("gwd-ad","https://www.odomzo.com/hcp/oncology?utm_source=banner&utm_medium=PM-US-ODZ-0745&utm_campaign=sensified",true,"page1")};</script>
  <script type="text/javascript" gwd-events="registration">gwd.actions.events.registerEventHandlers=function(event){gwd.actions.events.addHandler("page1","event-1",gwd.startAutoScroll,false);gwd.actions.events.addHandler("gwd-taparea","action",gwd.auto_Gwd_taparea_1Action,false);gwd.actions.timeline.captureAnimationEnd(document.body)};gwd.actions.events.deregisterEventHandlers=function(event){gwd.actions.events.removeHandler("page1","event-1",gwd.startAutoScroll,false);gwd.actions.events.removeHandler("gwd-taparea","action",gwd.auto_Gwd_taparea_1Action,false);gwd.actions.timeline.releaseAnimationEnd(document.body)};document.addEventListener("DOMContentLoaded",gwd.actions.events.registerEventHandlers);document.addEventListener("unload",gwd.actions.events.deregisterEventHandlers);</script>
  <script data-source="gwdtaparea_min.js" data-version="7" data-exports-type="gwd-taparea" src="gwdtaparea_min.js"></script>
  <script data-source="gwdgenericad_min.js" data-version="8" data-exports-type="gwd-genericad" src="gwdgenericad_min.js"></script>
  <script data-source="gwdimage_min.js" data-version="17" data-exports-type="gwd-image" src="gwdimage_min.js"></script>
</head>

<body>
  <gwd-genericad id="gwd-ad">
    <gwd-pagedeck class="gwd-page-container" id="pagedeck">
      <gwd-page id="page1" class="gwd-page-wrapper gwd-page-size gwd-lightbox gwd-page-1ksv" data-gwd-width="320px" data-gwd-height="50px">
        <div class="gwd-page-content gwd-page-size gwd-div-1dtg">
          <span class="gwd-span-1rxo" id="scrollingISI"><div class="gwd-div-1p8h">
            <p>
              laBCC=locally advanced basal cell carcinoma
            </p>
            <table align="center" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr>
<td bgcolor="#ffffff" height="1"></td>
</tr>
</tbody></table>
            <table align="center" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr>
<td valign="middle" style="border: 1px solid #58595b; padding: 3px 2px 2px 2px;"><p class="gwd-span-i4jd">WARNING: EMBRYO-FETAL TOXICITY</p>
<ul>
<li><span>ODOMZO can cause embryo-fetal death or severe birth defects when administered to a pregnant woman. ODOMZO is embryotoxic, fetotoxic, and teratogenic in animals</span>
          </li>
          <li><span>Verify the pregnancy status of females of reproductive potential prior to initiating therapy. Advise females of reproductive potential to use effective contraception during treatment with ODOMZO and for at least 20 months after the last dose</span>
          </li>
          <li><span>Advise males of the potential risk of exposure through semen and to use condoms with a pregnant partner or a female partner of reproductive potential during treatment with ODOMZO and for at least 8 months after the last dose</span>
          </li>
          </ul>
          </td>
          </tr>
          </tbody>
          </table>
          <table align="center" border="0" cellpadding="0" cellspacing="0" width="100%">
            <tbody>
              <tr>
                <td bgcolor="#ffffff" height="3"></td>
              </tr>
            </tbody>
          </table>
          <p class="gwd-p-14bg">INDICATION</p>
          <p>ODOMZO<sup>®</sup> (sonidegib) is indicated for the treatment of adult patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.
          </p>
          <p class="gwd-p-14bg">IMPORTANT SAFETY INFORMATION</p>
          <p class="gwd-p-14bg">WARNINGS AND PRECAUTIONS</p>
          <p><span class="gwd-p-14bg">Embryo-fetal Toxicity:</span> ODOMZO can cause embryo-fetal death or severe birth defects when administered to a pregnant woman. <em>Females of Reproductive Potential:</em> Verify pregnancy status prior to initiating ODOMZO. Advise females to use effective contraception and not to breastfeed, due to the potential for serious adverse reactions in breastfed infants, during treatment and for at least 20 months after the last dose. Report pregnancies to Sun Pharmaceutical Industries, Inc. at 1-800-406-7984.</p>
          <p><em>Males:</em> Advise males to use condoms, even after a vasectomy, and to not donate semen during treatment and for at least 8 months after the last dose to avoid potential drug exposure in pregnant females or females of reproductive potential.</p>
          <p><em>Blood Donation:</em> Advise patients not to donate blood or blood products while taking ODOMZO, and for at least 20 months after the last dose because their blood or blood products might be given to a female of reproductive potential.</p>
          <p><span class="gwd-p-14bg">Musculoskeletal Adverse Reactions:</span> Musculoskeletal adverse reactions, which may be accompanied by serum creatine kinase (CK) elevations, occur with ODOMZO and other drugs which inhibit the hedgehog (Hh) pathway. Obtain serum CK and creatinine levels prior to initiating therapy, periodically during treatment, and as clinically indicated. Temporary dose interruption or discontinuation of ODOMZO may be required based on the severity of musculoskeletal adverse reactions.</p>
          <p><span class="gwd-p-14bg">Premature Fusion of the Epiphyses:</span> ODOMZO is not indicated for use in pediatric patients. Premature fusion of the epiphyses has been reported in pediatric patients exposed to ODOMZO and other Hh pathway inhibitors. In some cases, fusion progressed after discontinuation.</p>
          <p><span class="gwd-p-14bg">Drug Interactions:</span> Avoid concomitant administration of ODOMZO with strong and moderate CYP3A inhibitors. If a moderate CYP3A inhibitor must be used, administer for less than 14 days and monitor closely for adverse reactions, particularly musculoskeletal. Avoid concomitant administration of ODOMZO with strong and moderate CYP3A inducers.</p>
          <p><span class="gwd-p-14bg">Geriatric Use:</span> There was a higher incidence of serious adverse events, Grade 3 and 4, and events requiring dose interruption or discontinuation in patients ≥65 years compared with younger patients; this was not attributable to an increase in any specific adverse event.</p>
          <p><span class="gwd-p-14bg">Most Common Adverse Reactions:</span> The most common adverse reactions occurring in ≥10% of patients were muscle spasms (54%), alopecia (53%), dysgeusia (46%), fatigue (41%), nausea (39%), musculoskeletal pain (32%), diarrhea (32%), decreased weight (30%), decreased appetite (23%), myalgia (19%), abdominal pain (18%), headache (15%), pain (14%), vomiting (11%), and pruritus (10%).</p>
          <p class="gwd-p-1bk2">Please see the full <a href=clickTag class="gwd-a-db9d" target="_blank">Prescribing Information</a> for ODOMZO, including Boxed WARNING.</p>
          <p><span class="gwd-span-1uuf">References: 1.</span> ODOMZO [prescribing information]. Cranbury, NJ: Sun Pharmaceutical Industries, Inc.; 08/2023. <span class="gwd-span-wj62">2.</span> Lear JT, Migden MR, Lewis KD, et al. Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study. J Eur Acad Dermatol Venereol. 2018;32(3):372-381</p>
          <table align="center" border="0" cellpadding="0" cellspacing="0" width="100%">
            <tbody>
              <tr>
                <td bgcolor="#ffffff" height="3"></td>
              </tr>
              <tr>
                <td bgcolor="#58595b" height="1"></td>
              </tr>
              <tr>
                <td bgcolor="#ffffff" height="3"></td>
              </tr>
            </tbody>
          </table>
          <p>© 2024 Sun Pharmaceutical Industries, Inc. All rights reserved.<br>PM-US-ODZ-0745<br>09/2024</p>
          <table cellspacing="0" cellpadding="0" border="0" width="100%">
            <tbody>
              <tr>
                <td style="text-align: center; padding: 3px 0px 0px 0px;">
                  <a href="https://sunpharma.com/usa/" target="_blank">
                    <gwd-image id="sun-pharma-sm" source="assets/sun-pharma-sm.png" scaling="stretch" class="gwd-image-zitl"></gwd-image>
                  </a>
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        </span>
        <div class="gwd-animation-event event-1-animation" data-event-name="event-1" data-event-time="6000"></div>
        <gwd-image id="grad-back" source="assets/grad-back.jpg" scaling="stretch" class="gwd-image-2t8t"></gwd-image>
        <gwd-image id="odomozo-logo" source="assets/odomozo-logo.png" scaling="stretch" class="gwd-image-1bf9"></gwd-image>
        <gwd-image id="for-treament" source="assets/for-treament.png" scaling="stretch" class="gwd-image-ise7 gwd-gen-1s2wgwdanimation"></gwd-image>
        <gwd-image id="title-only-hii" source="assets/title-only-hii.png" scaling="stretch" class="gwd-image-15ie gwd-gen-wcdwgwdanimation"></gwd-image>
        <gwd-image id="foot-based-on" source="assets/foot-based-on.png" scaling="stretch" class="gwd-image-wtur gwd-gen-1uo0gwdanimation"></gwd-image>
        <gwd-image id="cta-button" source="assets/cta-button.png" scaling="stretch" class="gwd-image-10ur gwd-gen-12thgwdanimation"></gwd-image>
        <svg data-gwd-shape="line" preserveAspectRatio="none" viewBox="0 0 320 1" class="gwd-line-llrz">
          <line x1="0" x2="320" y1="0.5" y2="0.5"></line>
        </svg>
        <svg data-gwd-shape="line" preserveAspectRatio="none" viewBox="0 0 320 1" class="gwd-svg-1bll">
          <line x1="0" x2="320" y1="0.5" y2="0.5"></line>
        </svg>
        <svg data-gwd-shape="line" preserveAspectRatio="none" viewBox="0 0 1 50" class="gwd-line-laae">
          <line x1="0.5" x2="0.5" y1="0" y2="50"></line>
        </svg>
        <svg data-gwd-shape="line" preserveAspectRatio="none" viewBox="0 0 1 50" class="gwd-svg-o91e">
          <line x1="0.5" x2="0.5" y1="0" y2="50"></line>
        </svg>
        <gwd-taparea id="gwd-taparea" class="gwd-taparea-1xpo"></gwd-taparea>
        </div>
      </gwd-page>
    </gwd-pagedeck>
  </gwd-genericad>
  <script type="text/javascript" id="gwd-init-code">
    (function() {
      var gwdAd = document.getElementById('gwd-ad');

      /**
       * Handles the DOMContentLoaded event. The DOMContentLoaded event is
       * fired when the document has been completely loaded and parsed.
       */
      function handleDomContentLoaded(event) {

      }

      /**
       * Handles the WebComponentsReady event. This event is fired when all
       * custom elements have been registered and upgraded.
       */
      function handleWebComponentsReady(event) {
        // Start the Ad lifecycle.
        requestAnimationFrame(function() {
          setTimeout(function() {
            gwdAd.initAd();
          }, 1);
        });
      }

      /**
       * Handles the event that is dispatched after the Ad has been
       * initialized and before the default page of the Ad is shown.
       */
      function handleAdInitialized(event) {}

      window.addEventListener('DOMContentLoaded',
        handleDomContentLoaded, false);
      window.addEventListener('WebComponentsReady',
        handleWebComponentsReady, false);
      window.addEventListener('adinitialized',
        handleAdInitialized, false);
    })();
  </script>


</body></html>
